Your browser doesn't support javascript.
loading
Neutrophil specific granule and NETosis defects in gray platelet syndrome.
Aarts, Cathelijn E M; Downes, Kate; Hoogendijk, Arie J; Sprenkeler, Evelien G G; Gazendam, Roel P; Favier, Rémi; Favier, Marie; Tool, Anton T J; van Hamme, John L; Kostadima, Myrto A; Waller, Kate; Zieger, Barbara; van Bergen, Maaike G J M; Langemeijer, Saskia M C; van der Reijden, Bert A; Janssen, Hans; van den Berg, Timo K; van Bruggen, Robin; Meijer, Alexander B; Ouwehand, Willem H; Kuijpers, Taco W.
Afiliação
  • Aarts CEM; Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.
  • Downes K; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Hoogendijk AJ; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Sprenkeler EGG; Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.
  • Gazendam RP; Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.
  • Favier R; Emma Children's Hospital, Department of Pediatric Immunology, Rheumatology and Infectious Disease, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Favier M; Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.
  • Tool ATJ; Assistance Publique-Hôpitaux de Paris, Centre de Reference des Pathologies Plaquettaires, Hôpitaux Armand Trousseau, Bicêtre, Robert Debré, Paris, France.
  • van Hamme JL; INSERM Unité Mixte de Recherche (UMR) 1170, Gustave Roussy Cancer Campus, Universite Paris-Saclay, Villejuif, France.
  • Kostadima MA; Assistance Publique-Hôpitaux de Paris, Centre de Reference des Pathologies Plaquettaires, Hôpitaux Armand Trousseau, Bicêtre, Robert Debré, Paris, France.
  • Waller K; INSERM Unité Mixte de Recherche (UMR) 1170, Gustave Roussy Cancer Campus, Universite Paris-Saclay, Villejuif, France.
  • Zieger B; Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.
  • van Bergen MGJM; Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.
  • Langemeijer SMC; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • van der Reijden BA; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Janssen H; Department of Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany.
  • van den Berg TK; Department of Laboratory Medicine, Laboratory of Hematology, Radboud Institute of Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Bruggen R; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Meijer AB; Department of Laboratory Medicine, Laboratory of Hematology, Radboud Institute of Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Ouwehand WH; Division of Cell Biology, Netherlands Cancer Institute, Amsterdam, The Netherlands; and.
  • Kuijpers TW; Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.
Blood Adv ; 5(2): 549-564, 2021 01 26.
Article em En | MEDLINE | ID: mdl-33496751
Gray platelet syndrome (GPS) is an autosomal recessive bleeding disorder characterized by a lack of α-granules in platelets and progressive myelofibrosis. Rare loss-of-function variants in neurobeachin-like 2 (NBEAL2), a member of the family of beige and Chédiak-Higashi (BEACH) genes, are causal of GPS. It is suggested that BEACH domain containing proteins are involved in fusion, fission, and trafficking of vesicles and granules. Studies in knockout mice suggest that NBEAL2 may control the formation and retention of granules in neutrophils. We found that neutrophils obtained from the peripheral blood from 13 patients with GPS have a normal distribution of azurophilic granules but show a deficiency of specific granules (SGs), as confirmed by immunoelectron microscopy and mass spectrometry proteomics analyses. CD34+ hematopoietic stem cells (HSCs) from patients with GPS differentiated into mature neutrophils also lacked NBEAL2 expression but showed similar SG protein expression as control cells. This is indicative of normal granulopoiesis in GPS and identifies NBEAL2 as a potentially important regulator of granule release. Patient neutrophil functions, including production of reactive oxygen species, chemotaxis, and killing of bacteria and fungi, were intact. NETosis was absent in circulating GPS neutrophils. Lack of NETosis is suggested to be independent of NBEAL2 expression but associated with SG defects instead, as indicated by comparison with HSC-derived neutrophils. Since patients with GPS do not excessively suffer from infections, the consequence of the reduced SG content and lack of NETosis for innate immunity remains to be explored.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article